Wholehealth Products Inc. (GWPC) Financials Nov 18, 2014, 4:12 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Wholehealth Products Inc.
Fiscal year is September-August. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 0 0 0 0 0
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 0 0 0 0 0
Depreciation 0 0 0 0 0
Amortization of Intangibles 0 0 0 0 0
Gross Income 0 0 0 0 0
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 12,000 12,000 12,000 46.82M 33.32M
Research & Development - - - 0 -
Other SG&A 12,000 12,000 12,000 46.82M 33.32M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 0 0 0 0 6,138
Gross Interest Expense 0 0 0 0 6,138
Interest Capitalized 0 0 0 0 0
Pretax Income (12,000) (12,000) (12,000) (46.82M) (33.32M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (12,000) (12,000) (12,000) (46.82M) (33.32M)
Minority Interest Expense 0 0 0 0 0
Net Income (12,000) (12,000) (12,000) (46.82M) (33.32M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (12,000) (12,000) (12,000) (46.82M) (33.32M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (12,000) (12,000) (12,000) (46.82M) (33.32M)
EPS (Basic) () () () (97.50) (1.14)
Basic Shares Outstanding 413,954 413,954 413,954 478,057 29.36M
EPS (Diluted) () () () (97.50) (1.14)
Diluted Shares Outstanding 413,954 413,954 413,954 478,057 29.36M
EBITDA (12,000) (12,000) (12,000) (46.82M) (33.32M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Wholehealth Products Inc.
Fiscal year is September-August. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 0 0 0 0 0
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 0 0 0 0 0
Depreciation 0 0 0 0 0
Amortization of Intangibles 0 0 0 0 0
Gross Income 0 0 0 0 0
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 12,000 12,000 12,000 46.82M 33.32M
Research & Development - - - 0 -
Other SG&A 12,000 12,000 12,000 46.82M 33.32M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 0 0 0 0 6,138
Gross Interest Expense 0 0 0 0 6,138
Interest Capitalized 0 0 0 0 0
Pretax Income (12,000) (12,000) (12,000) (46.82M) (33.32M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (12,000) (12,000) (12,000) (46.82M) (33.32M)
Minority Interest Expense 0 0 0 0 0
Net Income (12,000) (12,000) (12,000) (46.82M) (33.32M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (12,000) (12,000) (12,000) (46.82M) (33.32M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (12,000) (12,000) (12,000) (46.82M) (33.32M)
EPS (Basic) () () () (97.50) (1.14)
Basic Shares Outstanding 413,954 413,954 413,954 478,057 29.36M
EPS (Diluted) () () () (97.50) (1.14)
Diluted Shares Outstanding 413,954 413,954 413,954 478,057 29.36M
EBITDA (12,000) (12,000) (12,000) (46.82M) (33.32M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
